Scientists in Asia and Africa are racing to discover hardier crop varieties using gene editing tools. But patent restrictions ...

We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. In this article, we are going to take ...

Preliminary data demonstrate that CTX112™ has the potential to provide meaningful clinical benefit with a well-tolerated ...

Researchers expand the CRISPR genome engineering toolbox with transposase-assisted target-site integration (TATSI), a ...

Researchers from the University of Illinois have reported complementary discoveries that will improve scientists' ...

How does CRISPR work, and why is editing human embryos so controversial? Explore the science, the risks, and the ethical debates surrounding Dr. He Jiankui’s gene-editing experiment.

Research analysts at William Blair issued their FY2024 earnings per share estimates for shares of CRISPR Therapeutics in a report issued on Monday, December 9th. William Blair analyst S. Corwin ...

A research team have recently published their article, "Rationally designed pooled CRISPRi-seq uncovers an inhibitor of ...

When hiring job candidates to work on cell and gene therapies, companies look for more than just technical skills. Talent ...

A new kind of cancer gene therapy can be remotely activated at a specific part of the body. The team developed a version of ...

The era of artificial intelligence has already begun and we talk more about its risks than its possibilities. Can we allow ...

The new company has also raised $75 million that will support the development of epigenetic editing therapies for hepatitis B ...